Snowball logo
logo
PACB_logo

Pacific Biosciences of California, Inc

PACB β€’ NASDAQ
$1.52+$0.24Β  (18.75%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
130.5128.3200.5154160159.3
COGS
71.6579.27147.7116.7109.3102
Gross Profit
58.8649.0352.7837.2850.6757.3
Operating Expenses & Income
Operating Income
(210.4)(307.2)(334.5)(474.3)(557.6)(162.5)
Total Operating Expenses
269.3356.2387.2511.6608.2219.8
R&D Expenses
112.9193187.2134.997.3188.36
Selling General & Admin Expenses
124.1160.9168.8175141.596.3
Earnings from Continuing Operations
Interest Expense
(12.53)(14.69)(14.34)(13.41)(6.954)(3.849)
Interest Income
------
Income Tax Expense
(93.65)(17.32)(11.42)0.3160.3180.827
Net Income
Net Income
(181.2)(314.2)(306.7)(309.9)(546.4)(131.4)
Supplemental
EBIT
(262.3)(299.6)(303.8)(296.1)(539.1)-
EBITDA
(250.8)(282.2)(271.1)(242.8)(34.2)(113.6)
In millions of USD, except % and values per 1 share